Coya Therapeutics (COYA) Equity Average (2023 - 2025)
Historic Equity Average for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $27.8 million.
- Coya Therapeutics' Equity Average fell 1735.18% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year decrease of 1735.18%. This contributed to the annual value of $37.6 million for FY2024, which is 17609.03% up from last year.
- Latest data reveals that Coya Therapeutics reported Equity Average of $27.8 million as of Q3 2025, which was down 1735.18% from $30.8 million recorded in Q2 2025.
- Coya Therapeutics' 5-year Equity Average high stood at $36.5 million for Q1 2025, and its period low was $3.9 million during Q1 2023.
- For the 3-year period, Coya Therapeutics' Equity Average averaged around $26.0 million, with its median value being $30.8 million (2025).
- In the last 5 years, Coya Therapeutics' Equity Average soared by 77679.99% in 2024 and then tumbled by 1735.18% in 2025.
- Coya Therapeutics' Equity Average (Quarter) stood at $22.9 million in 2023, then surged by 56.56% to $35.8 million in 2024, then dropped by 22.34% to $27.8 million in 2025.
- Its Equity Average was $27.8 million in Q3 2025, compared to $30.8 million in Q2 2025 and $36.5 million in Q1 2025.